Found 289 matching trials
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh
PHASE3Oral polio and rotavirus vaccines are significantly less effective in child...
Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)
PHASE2The objective of this study is to compare the antibody response 30 days aft...
Location
Garuda Primary Health Center
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately
PHASE3This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Location
Multiple Locations
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)
PHASE3This study will determine whether participants who receive the vaccine V419...
Location
Multiple Locations
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)
PHASE3To evaluate the immune response and the safety of a primary series schedule...
Location
Multiple Locations
Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers
PHASE3This study aims to evaluate the persistence of anti-poliovirus antibodies i...
Location
GSK Investigational Site
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
PHASE3This study evaluates the immunogenicity and safety of Infanrix hexa™ (DTPa-...
Location
GSK Investigational Site
Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants
PHASE3This is a follow-up of the primary series vaccination schedule in Study A3L...
Location
Multiple Locations
Evaluation of Marketing Interventions in Colombia
NAThe proposed project seeks to implement a cluster-randomized controlled tri...
Location
World Food Programme Colombia
Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
PHASE2This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Location
GSK Investigational Site